Publications by authors named "Ayana Pai"
Introduction: Alzheimer's disease (AD) lacks a less invasive and early detectable biomarker. Here, we investigated the biomarker potential of miR-501-3p and miR-502-3p using different AD sources.
Methods: MiR-501-3p and miR-502-3p expressions were evaluated in AD CSF exosomes, serum exosomes, familial and sporadic AD fibroblasts and B-lymphocytes by qRT-PCR analysis.
Article Synopsis
- Respiratory syncytial virus (RSV) poses serious health risks for young children and elderly individuals, with current vaccines mainly available for adults over 60 and temporary protection for infants through maternal antibodies.
- Researchers have developed a new type of vaccine that uses an anti-idiotypic monoclonal antibody (ai-mAb) specifically designed to target B cell receptors capable of producing RSV-neutralizing antibodies.
- This novel approach effectively engages the right B cells without triggering unwanted immune responses, showcasing potential for a more effective infant vaccine against RSV.